These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 33097426

  • 61. Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States.
    McGann P, Kwak YI, Summers A, Cummings JF, Waterman PE, Lesho EP.
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1116-9. PubMed ID: 22011540
    [Abstract] [Full Text] [Related]

  • 62. Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure.
    Schlett CD, Millar EV, Crawford KB, Cui T, Lanier JB, Tribble DR, Ellis MW.
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4404-10. PubMed ID: 24841265
    [Abstract] [Full Text] [Related]

  • 63. Recurrent Methicillin-Resistant Staphylococcus aureus Cutaneous Abscesses and Selection of Reduced Chlorhexidine Susceptibility during Chlorhexidine Use.
    Johnson RC, Schlett CD, Crawford K, Lanier JB, Merrell DS, Ellis MW.
    J Clin Microbiol; 2015 Nov; 53(11):3677-82. PubMed ID: 26292295
    [Abstract] [Full Text] [Related]

  • 64. Cell-wall thickness: possible mechanism of acriflavine resistance in meticillin-resistant Staphylococcus aureus.
    Kawai M, Yamada S, Ishidoshiro A, Oyamada Y, Ito H, Yamagishi JI.
    J Med Microbiol; 2009 Mar; 58(Pt 3):331-336. PubMed ID: 19208883
    [Abstract] [Full Text] [Related]

  • 65. Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide In Vitro and In Vivo.
    Renzoni A, Von Dach E, Landelle C, Diene SM, Manzano C, Gonzales R, Abdelhady W, Randall CP, Bonetti EJ, Baud D, O'Neill AJ, Bayer A, Cherkaoui A, Schrenzel J, Harbarth S, François P.
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784678
    [Abstract] [Full Text] [Related]

  • 66. Decreased susceptibility to chlorhexidine and prevalence of disinfectant resistance genes among clinical isolates of Staphylococcus epidermidis.
    Prag G, Falk-Brynhildsen K, Jacobsson S, Hellmark B, Unemo M, Söderquist B.
    APMIS; 2014 Oct; 122(10):961-7. PubMed ID: 24628476
    [Abstract] [Full Text] [Related]

  • 67. Phenotypic chlorhexidine and triclosan susceptibility in clinical Staphylococcus aureus isolates in Australia.
    Hughes C, Ferguson J.
    Pathology; 2017 Oct; 49(6):633-637. PubMed ID: 28811083
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications.
    McNeil JC, Hulten KG, Kaplan SL, Mahoney DH, Mason EO.
    Pediatr Infect Dis J; 2013 Feb; 32(2):124-8. PubMed ID: 22976051
    [Abstract] [Full Text] [Related]

  • 72. Susceptibility to chlorhexidine amongst multidrug-resistant clinical isolates of Staphylococcus epidermidis from bloodstream infections.
    Hijazi K, Mukhopadhya I, Abbott F, Milne K, Al-Jabri ZJ, Oggioni MR, Gould IM.
    Int J Antimicrob Agents; 2016 Jul; 48(1):86-90. PubMed ID: 27230473
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.
    Wootton M, Walsh TR, Davies EM, Howe RA.
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):226-32. PubMed ID: 19199533
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Prevalence and genotypic relatedness of methicillin resistant Staphylococcus aureus in a tertiary care hospital.
    Fomda BA, Thokar MA, Bashir G, Khan A, Kour A, Zahoor D, Ray P.
    J Postgrad Med; 2014 Mar; 60(4):386-9. PubMed ID: 25370547
    [Abstract] [Full Text] [Related]

  • 78. Characterization of Heterogeneous MRSA and MSSA with Reduced Susceptibility to Chlorhexidine in Kuwaiti Hospitals.
    Vali L, Dashti AA, Mathew F, Udo EE.
    Front Microbiol; 2017 Mar; 8():1359. PubMed ID: 28775716
    [Abstract] [Full Text] [Related]

  • 79. Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome.
    Noguchi N, Nakaminami H, Nishijima S, Kurokawa I, So H, Sasatsu M.
    J Clin Microbiol; 2006 Jun; 44(6):2119-25. PubMed ID: 16757607
    [Abstract] [Full Text] [Related]

  • 80. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
    Aydeniz Ozansoy F, Cevahir N, Kaleli İ.
    Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.